Skip to content
★ Sign in to follow
AC

Angel Cabrera

Inovio Pharmaceuticals, Inc.Petsmart Inc
Total declarations
28
Companies
2
▲ Purchases (3 ops.)
€125k
▼ Sales (0 ops.)
—

Latest filing published 08 May 2020 for INOVIO PHARMACEUTICALS, INC..

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
33%
Median T+90
-14.0%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Angel Cabrera: trading record in brief

Filings by Angel Cabrera span 2 companies, the busiest being Petsmart Inc and Inovio Pharmaceuticals, Inc. We count 28 filings; the first trade dates from 9 December 2010 and the latest from 8 May 2020.

The open-market record is one-sided, with 3 purchases worth €125k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 16 share grants and 5 option exercises.

Half of the purchases are above €36k and half below. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -14.0%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 8 May 2020, reports an option exercise in Inovio Pharmaceuticals, Inc. The last purchase on record was published on 13 April 2015, which is 4,228 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Angel Cabrera

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total

25 of 28 declarations